Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 98 articles:
HTML format



Single Articles


    June 2021
  1. HEINE J, Fowler E, Scott CG, Jensen MR, et al
    Mammographic Variation Measures, Breast Density, and Breast Cancer Risk.
    AJR Am J Roentgenol. 2021 Jun 23:1-10. doi: 10.2214/AJR.20.22794.
    PubMed     Abstract available


  2. RAZA S
    Management of High-Risk Breast Lesions: Counterpoint-Time for Personalized Surveillance.
    AJR Am J Roentgenol. 2021;216:1434-1435.
    PubMed    


  3. CALHOUN BC
    Management of High-Risk Breast Lesions: Point-Surveillance Is a Change in Practice Preceding Evidence-Based Standardization.
    AJR Am J Roentgenol. 2021;216:1432-1433.
    PubMed    


    May 2021
  4. NIELL BL, Augusto B, McIntyre M, Conley CC, et al
    Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    AJR Am J Roentgenol. 2021 May 12:1-8. doi: 10.2214/AJR.20.23333.
    PubMed     Abstract available


  5. MOORMAN SEH, Pujara AC, Sakala MD, Neal CH, et al
    Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
    AJR Am J Roentgenol. 2021 May 6:1-8. doi: 10.2214/AJR.20.23467.
    PubMed     Abstract available


  6. CHOU SS, Baikpour M, Zhang W, Mercaldo SF, et al
    Shear-Wave Elastography of the Breast: Impact of Technical Image Quality Parameters on Diagnostic Accuracy.
    AJR Am J Roentgenol. 2021;216:1205-1215.
    PubMed     Abstract available


    April 2021
  7. KIM JJ, Kim JY, Hwangbo L, Suh HB, et al
    Ultrafast Dynamic Contrast-Enhanced MRI Using Compressed Sensing: Associations of Early Kinetic Parameters With Prognostic Factors of Breast Cancer.
    AJR Am J Roentgenol. 2021 Apr 28:1-8. doi: 10.2214/AJR.20.23457.
    PubMed     Abstract available


  8. MANGO VL, Heller SL
    Beyond the AJR: "Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women".
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25913.
    PubMed    


  9. KUNJUMMEN J, Rodriguez K, Newell MS, Hanley K, et al
    Management of Lobular Neoplasia Found on Core Needle Biopsy Performed for Calcifications Using Precise Radiologic-Pathologic Correlation.
    AJR Am J Roentgenol. 2021 Apr 14:1-10. doi: 10.2214/AJR.19.22599.
    PubMed     Abstract available


    March 2021
  10. HOGAN MP, Amir T, Sevilimedu V, Sung J, et al
    Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia.
    AJR Am J Roentgenol. 2021 Mar 31:1-6. doi: 10.2214/AJR.20.23480.
    PubMed     Abstract available


  11. CARNAHAN M, Pockaj B, Pizzitola V, Giurescu M, et al
    Contrast-Enhanced Mammography for Newly Diagnosed Breast Cancer in Women With Breast Augmentation: Preliminary Findings.
    AJR Am J Roentgenol. 2021 Mar 17. doi: 10.2214/AJR.20.25341.
    PubMed     Abstract available


    February 2021
  12. NGUYEN DL, Liang A, Mullen LA, Oluyemi E, et al
    Diagnostic Mammography for Post-Lumpectomy Surveillance in Women with Breast Cancer: Annual Frequencies of Additional Imaging and Recurrent Cancer.
    AJR Am J Roentgenol. 2021 Feb 24. doi: 10.2214/AJR.20.25417.
    PubMed     Abstract available


  13. TEICHGRAEBER DC, Guirguis MS, Whitman GJ
    Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual 8th Edition and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging.
    AJR Am J Roentgenol. 2021 Feb 17. doi: 10.2214/AJR.20.25223.
    PubMed     Abstract available


  14. NEAL CH, Joe AI, Patterson SK, Pujara AC, et al
    Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
    AJR Am J Roentgenol. 2021 Feb 17:1-7. doi: 10.2214/AJR.20.23314.
    PubMed     Abstract available


  15. RAUSCHER GH, Murphy AM, Qiu Q, Dolecek TA, et al
    The "Sweet Spot" Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry.
    AJR Am J Roentgenol. 2021 Feb 10:1-9. doi: 10.2214/AJR.19.22429.
    PubMed     Abstract available


  16. BERG WA, Rafferty EA, Friedewald SM, Hruska CB, et al
    Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021;216:275-294.
    PubMed     Abstract available


    January 2021
  17. MICHAELS AY, Ginter PS, Dodelzon K, Naunheim MR, et al
    High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
    AJR Am J Roentgenol. 2021 Jan 13:1-11. doi: 10.2214/AJR.20.23040.
    PubMed     Abstract available


  18. ECKSTEIN DA, Price ER, Hayward JH, Joe BN, et al
    Frequency and Outcomes of New Suspicious Lesions on Breast MRI in the Setting of Neoadjuvant Therapy.
    AJR Am J Roentgenol. 2021 Jan 13:1-7. doi: 10.2214/AJR.20.22979.
    PubMed     Abstract available


  19. MORI N, Sheth D, Abe H
    Reply to "Differentiating Benign Lesions From Areas of Malignant Nonmass Enhancement With MRI".
    AJR Am J Roentgenol. 2021;216:W8.
    PubMed    


  20. FORERO PA, Jimenez GP, Enciso JR
    Differentiating Benign Lesions From Areas of Malignant Nonmass Enhancement With MRI.
    AJR Am J Roentgenol. 2021;216:W7.
    PubMed    


    December 2020
  21. GUPTA D, Mendelson EB, Karst I
    Nipple Discharge: Current Clinical and Imaging Evaluation.
    AJR Am J Roentgenol. 2020 Dec 9:1-10. doi: 10.2214/AJR.19.22025.
    PubMed     Abstract available


  22. EGHTEDARI M, Chong A, Rakow-Penner R, Ojeda-Fournier H, et al
    Current Status and Future of BI-RADS in Multimodality Breast Imaging, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.24894.
    PubMed     Abstract available


    November 2020
  23. LOWRY KP, Sippo DA
    Beyond the AJR: "Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk".
    AJR Am J Roentgenol. 2020 Nov 25. doi: 10.2214/AJR.20.25138.
    PubMed    


  24. MILLER MM, Repich K, Patrie JT, Anderson RT, et al
    Patient Characteristics Associated with Patient-Reported Deterrents to Adjunct Breast Cancer Screening Among Patients with Dense Breasts.
    AJR Am J Roentgenol. 2020 Nov 4. doi: 10.2214/AJR.20.24516.
    PubMed     Abstract available


    October 2020
  25. MUZAHIR S
    Molecular Breast Cancer Imaging in the Era of Precision Medicine.
    AJR Am J Roentgenol. 2020 Oct 21:1-8. doi: 10.2214/AJR.20.22883.
    PubMed     Abstract available


  26. NEWELL MS
    Editorial Comment: Breast Cancer Skip Metastases-If You Look, You Will Find Them.
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24836.
    PubMed    


  27. WEAVER O, Yang W
    Imaging of Breast Cancers With Predilection for Nonmass Pattern of Growth: Invasive Lobular Carcinoma and DCIS-Does Imaging Capture It All?
    AJR Am J Roentgenol. 2020 Oct 6:1-8. doi: 10.2214/AJR.19.22027.
    PubMed     Abstract available


    September 2020
  28. CHUNG H, Sun J, Leung JWT
    Breast Cancer Skip Metastases: Frequency, Associated Tumor Characteristics, and Role of Staging Nodal Ultrasound in Detection.
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24371.
    PubMed     Abstract available


  29. CHIKARMANE SA, Cochon LR, Khorasani R, Sahu S, et al
    Screening Mammography Performance Metrics of 2D Digital Mammography Versus Digital Breast Tomosynthesis in Women With a Personal History of Breast Cancer.
    AJR Am J Roentgenol. 2020 Sep 23. doi: 10.2214/AJR.20.23976.
    PubMed     Abstract available


  30. NIELL BL, Abdalah M, Stringfield O, Raghunand N, et al
    Quantitative measures of background parenchymal enhancement predict breast cancer risk.
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.23804.
    PubMed     Abstract available


  31. POLAT DS, Evans WP, Dogan BE
    Contrast-Enhanced Digital Mammography: Technique, Clinical Applications, and Pitfalls.
    AJR Am J Roentgenol. 2020 Sep 2:1-12. doi: 10.2214/AJR.19.22412.
    PubMed     Abstract available


  32. BALLEYGUIER C
    Editorial Comment on "Mixed-methods study to predict upstaging of DCIS to invasive disease on mammography".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24467.
    PubMed    


  33. CHOUDHERY S, Johnson M, Fazzio RT
    Prone Versus Upright Digital Tomosynthesis-Guided Biopsy.
    AJR Am J Roentgenol. 2020;215:760-764.
    PubMed     Abstract available


    August 2020
  34. DIBBLE EH
    Editorial Comment on "Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study".
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24456.
    PubMed    


  35. MYERS KS, Oluyemi ET, Mullen LA, Ambinder EB, et al
    Outcomes of Foci on Breast MRI: Features Associated With Malignancy.
    AJR Am J Roentgenol. 2020 Aug 12:1-8. doi: 10.2214/AJR.19.22423.
    PubMed     Abstract available


  36. GRIMM LJ, Neely B, Hou R, Selvakumaran V, et al
    Mixed-methods study to predict upstaging of DCIS to invasive disease on mammography.
    AJR Am J Roentgenol. 2020 Aug 12. doi: 10.2214/AJR.20.23679.
    PubMed     Abstract available


    July 2020
  37. HRUSKA CB, Geske JR, Conners AL, Whaley DH, et al
    Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23854.
    PubMed     Abstract available


  38. GREENWOOD HI, Freimanis RI
    Commentary on "Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening".
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23674.
    PubMed    


  39. SCARANELO AM, Degani H, Grobgeld D, Talbot N, et al
    Effect of IV Administration of a Gadolinium-Based Contrast Agent on Breast Diffusion-Tensor Imaging.
    AJR Am J Roentgenol. 2020 Jul 29:1-7. doi: 10.2214/AJR.19.22085.
    PubMed     Abstract available


  40. PHAM R, Marshall H, Plecha D
    Abbreviated Protocol Breast MRI.
    AJR Am J Roentgenol. 2020 Jul 29:1-5. doi: 10.2214/AJR.19.22292.
    PubMed     Abstract available


  41. NARAYAN AK
    Commentary on "Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years".
    AJR Am J Roentgenol. 2020 Jul 22. doi: 10.2214/AJR.20.23693.
    PubMed    


  42. KARIMI Z, Phillips J, Slanetz P, Lotfi P, et al
    Factors Associated with Background Parenchymal Enhancement on Contrast Enhanced Mammography.
    AJR Am J Roentgenol. 2020 Jul 8. doi: 10.2214/AJR.19.22353.
    PubMed     Abstract available


    June 2020
  43. DIBBLE EH, Hunt KN, Ehman EC, O'Connor MK, et al
    Molecular Breast Imaging in Clinical Practice.
    AJR Am J Roentgenol. 2020 Jun 17:1-8. doi: 10.2214/AJR.19.22622.
    PubMed     Abstract available


    May 2020
  44. MORI N, Sheth D, Abe H
    Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
    AJR Am J Roentgenol. 2020 May 26:1-8. doi: 10.2214/AJR.19.21920.
    PubMed     Abstract available


  45. CHAPMAN MC, Hayward JH, Woodard GA, Joe BN, et al
    The Role of Breast MRI in Detecting Asymptomatic Recurrence After Therapeutic Mastectomy.
    AJR Am J Roentgenol. 2020 May 6:1-8. doi: 10.2214/AJR.19.21640.
    PubMed     Abstract available


    April 2020
  46. MANGO VL, Sun M, Wynn RT, Ha R, et al
    Should We Ignore, Follow, or Biopsy? Impact of Artificial Intelligence Decision Support on Breast Ultrasound Lesion Assessment.
    AJR Am J Roentgenol. 2020 Apr 22:1-8. doi: 10.2214/AJR.19.21872.
    PubMed     Abstract available


  47. DODELZON K, Simon K, Dou E, Levy AD, et al
    Performance of 2D Synthetic Mammography Versus Digital Mammography in the Detection of Microcalcifications at Screening.
    AJR Am J Roentgenol. 2020 Apr 7:1-9. doi: 10.2214/AJR.19.21598.
    PubMed     Abstract available


    March 2020
  48. BUTLER RS, Hooley RJ
    Screening Breast Ultrasound: Update After 10 Years of Breast Density Notification Laws.
    AJR Am J Roentgenol. 2020 Mar 17:1-12. doi: 10.2214/AJR.19.22275.
    PubMed     Abstract available


  49. LEE CH, Bryce Y, Zheng J, Sung JS, et al
    Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle.
    AJR Am J Roentgenol. 2020 Mar 11:1-7. doi: 10.2214/AJR.18.19960.
    PubMed     Abstract available


    February 2020
  50. LINDEN OE, Hayward JH, Price ER, Kelil T, et al
    Utility of Diagnostic Mammography as the Primary Imaging Modality for Palpable Lumps in Women With Almost Entirely Fatty Breasts.
    AJR Am J Roentgenol. 2020 Feb 5:1-7. doi: 10.2214/AJR.19.21760.
    PubMed     Abstract available


  51. LEWIN AA, Mercado CL
    Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
    AJR Am J Roentgenol. 2020;214:265-275.
    PubMed     Abstract available


  52. HUPPE AI, Brem RF
    Minimally Invasive Breast Procedures: Practical Tips and Tricks.
    AJR Am J Roentgenol. 2020;214:306-315.
    PubMed     Abstract available


  53. HOLBROOK AI
    Breast Pain, A Common Grievance: Guidance to Radiologists.
    AJR Am J Roentgenol. 2020;214:259-264.
    PubMed     Abstract available


  54. DESTOUNIS SV, Santacroce A, Arieno A
    Update on Breast Density, Risk Estimation, and Supplemental Screening.
    AJR Am J Roentgenol. 2020;214:296-305.
    PubMed     Abstract available


  55. LEE CS, Monticciolo DL, Moy L
    Screening Guidelines Update for Average-Risk and High-Risk Women.
    AJR Am J Roentgenol. 2020;214:316-323.
    PubMed     Abstract available


    January 2020
  56. VOLTERRANI L, Gentili F, Fausto A, Pelini V, et al
    Dual-Energy CT for Locoregional Staging of Breast Cancer: Preliminary Results.
    AJR Am J Roentgenol. 2020 Jan 15:1-8. doi: 10.2214/AJR.18.20953.
    PubMed     Abstract available


    December 2019
  57. MILON A, Wahab CA, Kermarrec E, Bekhouche A, et al
    Breast MRI: Is Faster Better?
    AJR Am J Roentgenol. 2019 Dec 11:1-14. doi: 10.2214/AJR.19.21924.
    PubMed     Abstract available


  58. COHEN EO, Tso HH, Leung JWT
    Multiple Bilateral Circumscribed Breast Masses Detected at Imaging: Review of Evidence for Management Recommendations.
    AJR Am J Roentgenol. 2019 Dec 11:1-6. doi: 10.2214/AJR.19.22061.
    PubMed     Abstract available


  59. SARDANELLI F, Cozzi A, Trimboli RM, Schiaffino S, et al
    Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
    AJR Am J Roentgenol. 2019 Dec 4:1-4. doi: 10.2214/AJR.19.21988.
    PubMed     Abstract available


  60. EDMONDS CE, Lamb LR, Mercaldo SF, Sippo DA, et al
    Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    AJR Am J Roentgenol. 2019 Dec 4:1-9. doi: 10.2214/AJR.19.21778.
    PubMed     Abstract available


    November 2019
  61. SUN SX, Moseley TW, Kuerer HM, Yang WT, et al
    Imaging-Based Approach to Axillary Lymph Node Staging and Sentinel Lymph Node Biopsy in Patients With Breast Cancer.
    AJR Am J Roentgenol. 2019 Nov 12:1-10. doi: 10.2214/AJR.19.22022.
    PubMed     Abstract available


    October 2019
  62. CHOUDHERY S
    CT-Guided Seed Localization in the Breast and Axilla.
    AJR Am J Roentgenol. 2019 Oct 31:1-4. doi: 10.2214/AJR.19.21885.
    PubMed     Abstract available


  63. DANG PA, Wang A, Senapati GM, Ip IK, et al
    Comparing Tumor Characteristics and Rates of Breast Cancers Detected by Screening Digital Breast Tomosynthesis and Full-Field Digital Mammography.
    AJR Am J Roentgenol. 2019 Oct 15:1-6. doi: 10.2214/AJR.18.21060.
    PubMed     Abstract available


    July 2019
  64. SASADA S, Masumoto N, Kimura Y, Kajitani K, et al
    Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT.
    AJR Am J Roentgenol. 2019 Jul 24:1-7. doi: 10.2214/AJR.19.21373.
    PubMed     Abstract available


    June 2019
  65. GREENWOOD HI, Wong JM, Mukhtar RA, Alvarado MD, et al
    Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
    AJR Am J Roentgenol. 2019 Jun 5:1-5. doi: 10.2214/AJR.19.21378.
    PubMed     Abstract available


  66. HUNT KN, Conners AL, Goetz MP, O'Connor MK, et al
    Comparison of (99m)Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy.
    AJR Am J Roentgenol. 2019 Jun 5:1-12. doi: 10.2214/AJR.18.20628.
    PubMed     Abstract available


    May 2019
  67. WARD RC, Lourenco AP, Mainiero MB
    Ultrasound-Guided Breast Cancer Cryoablation.
    AJR Am J Roentgenol. 2019 May 23:1-7. doi: 10.2214/AJR.19.21329.
    PubMed     Abstract available


  68. ULANER GA
    PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
    AJR Am J Roentgenol. 2019 May 7:1-12. doi: 10.2214/AJR.19.21177.
    PubMed     Abstract available


    March 2019
  69. SIPPO DA, Rutledge GM, Burk KS, Mercaldo SF, et al
    Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
    AJR Am J Roentgenol. 2019 Mar 19:1-7. doi: 10.2214/AJR.18.20566.
    PubMed     Abstract available


    February 2019
  70. LIN LLY, Gao Y, Lewin AA, Toth HK, et al
    Overstated Harms of Breast Cancer Screening? A Large Outcomes Analysis of Complications Associated With 9-Gauge Stereotactic Vacuum-Assisted Breast Biopsy.
    AJR Am J Roentgenol. 2019 Feb 11:1-8. doi: 10.2214/AJR.18.20421.
    PubMed     Abstract available


  71. GAO Y, Geras KJ, Lewin AA, Moy L, et al
    New Frontiers: An Update on Computer-Aided Diagnosis for Breast Imaging in the Age of Artificial Intelligence.
    AJR Am J Roentgenol. 2019;212:300-307.
    PubMed     Abstract available


    January 2019
  72. FUJII MH, Herschorn SD, Sowden M, Hotaling EL, et al
    Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
    AJR Am J Roentgenol. 2019 Jan 23:1-6. doi: 10.2214/AJR.18.20255.
    PubMed     Abstract available


  73. KIM S, Plemmons J, Hoang K, Chaudhuri D, et al
    Breast-Specific Gamma Imaging Versus MRI: Comparing the Diagnostic Performance in Assessing Treatment Response After Neoadjuvant Chemotherapy in Patients With Breast Cancer.
    AJR Am J Roentgenol. 2019 Jan 8:1-10. doi: 10.2214/AJR.17.18930.
    PubMed     Abstract available


  74. CODARI M, Schiaffino S, Sardanelli F, Trimboli RM, et al
    Artificial Intelligence for Breast MRI in 2008-2018: A Systematic Mapping Review.
    AJR Am J Roentgenol. 2019 Jan 2:1-13. doi: 10.2214/AJR.18.20389.
    PubMed     Abstract available


    December 2018
  75. LEE CS, Sickles EA, Moy L
    Risk Stratification for Screening Mammography: Benefits and Harms.
    AJR Am J Roentgenol. 2018 Dec 17:1-9. doi: 10.2214/AJR.18.20345.
    PubMed     Abstract available


  76. ROARK AA, Dang PA, Niell BL, Halpern EF, et al
    JOURNAL CLUB: Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer.
    AJR Am J Roentgenol. 2018 Dec 12:1-9. doi: 10.2214/AJR.18.19916.
    PubMed     Abstract available


    September 2018
  77. SORIN V, Yagil Y, Yosepovich A, Shalmon A, et al
    Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    AJR Am J Roentgenol. 2018 Sep 21:W1-W8. doi: 10.2214/AJR.17.19355.
    PubMed     Abstract available


  78. LEE CI, Zhu W, Onega TL, Germino J, et al
    The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.
    AJR Am J Roentgenol. 2018 Sep 20:W1-W7. doi: 10.2214/AJR.17.19350.
    PubMed     Abstract available


    May 2018
  79. JIANG Y, Inciardi MF, Edwards AV, Papaioannou J, et al
    Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breast Tissue.
    AJR Am J Roentgenol. 2018 May 24:1-10. doi: 10.2214/AJR.18.19516.
    PubMed     Abstract available


    April 2018
  80. SCHEEL JR, Kim E, Partridge SC, Lehman CD, et al
    MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
    AJR Am J Roentgenol. 2018 Apr 30:1-10. doi: 10.2214/AJR.17.18323.
    PubMed     Abstract available


  81. ROSE SL, Shisler JL
    Tomosynthesis Impact on Breast Cancer Screening in Patients Younger Than 50 Years Old.
    AJR Am J Roentgenol. 2018 Apr 9:1-4. doi: 10.2214/AJR.17.18839.
    PubMed     Abstract available


    February 2018
  82. JAVITT MC
    Section Editor's Notebook: Breast Cancer Screening-What Now, and What Next?
    AJR Am J Roentgenol. 2018;210:239-240.
    PubMed    


    January 2018
  83. CARTER KJ, Castro F, Morcos RN
    Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    AJR Am J Roentgenol. 2018 Jan 11:1-8. doi: 10.2214/AJR.17.18484.
    PubMed     Abstract available


    December 2017
  84. MALTEZ DE ALMEIDA JR
    Work in Progress: Subdividing MRI BI-RADS Category 4 Assessment.
    AJR Am J Roentgenol. 2017;209:W401.
    PubMed    


    November 2017
  85. WEAVER O, Leung JWT
    Biomarkers and Imaging of Breast Cancer.
    AJR Am J Roentgenol. 2017 Nov 22:1-8. doi: 10.2214/AJR.17.18708.
    PubMed     Abstract available


  86. LEE CS, Moy L, Joe BN, Sickles EA, et al
    Screening for Breast Cancer in Women Age 75 Years and Older.
    AJR Am J Roentgenol. 2017 Nov 7:1-8. doi: 10.2214/AJR.17.18705.
    PubMed     Abstract available


  87. MONTICCIOLO DL, Helvie MA, Hendrick RE
    Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    AJR Am J Roentgenol. 2017 Nov 1:1-7. doi: 10.2214/AJR.17.18629.
    PubMed     Abstract available


  88. NEAL CH, Rahman WT, Joe AI, Noroozian M, et al
    Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening.
    AJR Am J Roentgenol. 2017 Nov 1:1-7. doi: 10.2214/AJR.17.18120.
    PubMed     Abstract available


  89. DOGAN BE, Scoggins ME, Son JB, Wei W, et al
    American College of Radiology-Compliant Short Protocol Breast MRI for High-Risk Breast Cancer Screening: A Prospective Feasibility Study.
    AJR Am J Roentgenol. 2017 Nov 1:1-8. doi: 10.2214/AJR.17.18267.
    PubMed     Abstract available


    October 2017
  90. DESTOUNIS S, Santacroce A
    Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    AJR Am J Roentgenol. 2017 Oct 24:1-6. doi: 10.2214/AJR.17.18730.
    PubMed     Abstract available


  91. ABRAMSON RG, Lakomkin N, Hainline A, Kang H, et al
    The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
    AJR Am J Roentgenol. 2017 Oct 24:W1-W7. doi: 10.2214/AJR.17.18249.
    PubMed     Abstract available


  92. PATEL BK, Lee CS, Kosiorek HE, Newell MS, et al
    Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study.
    AJR Am J Roentgenol. 2017 Oct 24:1-6. doi: 10.2214/AJR.17.17923.
    PubMed     Abstract available


  93. LEE CS, Moy L, Friedewald SM, Sickles EA, et al
    Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.
    AJR Am J Roentgenol. 2017 Oct 18:1-5. doi: 10.2214/AJR.17.18704.
    PubMed     Abstract available


    September 2017
  94. AGASTHYA GA, D'Orsi E, Kim YJ, Handa P, et al
    Can Breast Compression Be Reduced in Digital Mammography and Breast Tomosynthesis?
    AJR Am J Roentgenol. 2017 Sep 20:W1-W11. doi: 10.2214/AJR.16.17615.
    PubMed     Abstract available


  95. YOUK JH, Kim SJ, Son EJ, Gweon HM, et al
    Comparison of Visual Assessment of Breast Density in BI-RADS 4th and 5th Editions With Automated Volumetric Measurement.
    AJR Am J Roentgenol. 2017;209:703-708.
    PubMed     Abstract available


    August 2017
  96. BROWN AL, Phillips J, Slanetz PJ, Fein-Zachary V, et al
    Clinical Value of Mammography in the Evaluation of Palpable Breast Lumps in Women 30 Years Old and Older.
    AJR Am J Roentgenol. 2017 Aug 4:1-8. doi: 10.2214/AJR.16.17088.
    PubMed     Abstract available


    July 2017
  97. JENA A, Taneja S, Singh A, Negi P, et al
    Reliability of 18F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study.
    AJR Am J Roentgenol. 2017 Jul 5:1-9. doi: 10.2214/AJR.16.17766.
    PubMed     Abstract available


    June 2017
  98. NATESAN R, Santiago L, Kalambo M, Martaindale S, et al
    The Impact of Patient Demographics on the Selection of Breast Imaging Centers.
    AJR Am J Roentgenol. 2017 Jun 28:W1-W10. doi: 10.2214/AJR.16.17305.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: